Stock listing
NASDAQ:CGTX Cognition Therapeutics, Inc. Stock
Home listing (NASDAQ) of Cognition Therapeutics, Inc.
Follow Cognition Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CGTX
$0.698 USD -0.041 (-5.6%)
Close on Oct 30, 2026
- Day range
- $0.645 – $0.722 USDOct 30, 2026
- Volume
- 557,208 sharesOct 30, 2026
- Market cap
- $66.39M USDAt the close on Oct 30, 2026 · price × 95.09M shares outstanding
- 52-week range
- $0.550 – $1.830 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $473,863 USDMedian day 402,850 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CGTX · Home | $0.698 USD | -0.041 (-5.6%) | 557,208 | $0.722 | $0.722 | $0.645 | $0.739 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CGTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.698 | -0.041 | -5.6% | $0.722 | $0.722 | $0.645 | 557,208 | |
| $0.739 | -0.010 | -1.3% | $0.738 | $0.754 | $0.724 | 185,863 | |
| $0.749 | -0.010 | -1.3% | $0.768 | $0.784 | $0.735 | 350,885 | |
| $0.759 | +0.064 | +9.2% | $0.695 | $0.772 | $0.690 | 312,954 | |
| $0.695 | -0.024 | -3.3% | $0.724 | $0.730 | $0.690 | 289,854 | |
| $0.719 | +0.018 | +2.6% | $0.691 | $0.730 | $0.662 | 571,536 | |
| $0.701 | -0.046 | -6.2% | $0.800 | $0.818 | $0.700 | 1,017,357 | |
| $0.747 | +0.013 | +1.7% | $0.740 | $0.757 | $0.740 | 297,045 | |
| $0.734 | +0.006 | +0.9% | $0.730 | $0.758 | $0.726 | 461,532 | |
| $0.727 | -0.003 | -0.4% | $0.751 | $0.758 | $0.714 | 576,304 | |
| $0.730 | -0.003 | -0.4% | $0.760 | $0.787 | $0.713 | 429,200 | |
| $0.733 | -0.044 | -5.7% | $0.758 | $0.766 | $0.720 | 687,700 | |
| $0.777 | -0.025 | -3.1% | $0.800 | $0.815 | $0.770 | 520,800 | |
| $0.802 | -0.055 | -6.4% | $0.905 | $0.930 | $0.767 | 3,757,100 | |
| $0.857 | -0.020 | -2.3% | $0.870 | $0.898 | $0.833 | 413,300 | |
| $0.877 | -0.018 | -2.0% | $0.900 | $0.919 | $0.874 | 316,900 | |
| $0.895 | -0.042 | -4.5% | $0.948 | $0.948 | $0.894 | 452,700 | |
| $0.937 | -0.003 | -0.3% | $0.933 | $0.959 | $0.927 | 201,600 | |
| $0.940 | +0.002 | +0.2% | $0.940 | $0.960 | $0.926 | 329,500 | |
| $0.938 | +0.013 | +1.4% | $0.944 | $0.970 | $0.919 | 326,800 | |
| $0.925 | +0.034 | +3.8% | $0.921 | $0.930 | $0.901 | 300,100 | |
| $0.891 | -0.069 | -7.2% | $0.980 | $0.988 | $0.890 | 791,700 | |
| $0.960 | +0.006 | +0.6% | $0.980 | $0.984 | $0.960 | 386,100 | |
| $0.954 | +0.016 | +1.7% | $0.960 | $0.980 | $0.933 | 525,100 | |
| $0.938 | +0.001 | +0.1% | $0.929 | $0.960 | $0.920 | 200,200 | |
| $0.937 | -0.014 | -1.5% | $0.980 | $0.980 | $0.934 | 540,000 | |
| $0.951 | +0.001 | +0.1% | $0.967 | $0.967 | $0.930 | 266,400 | |
| $0.950 | -0.031 | -3.2% | $1.000 | $1.010 | $0.950 | 563,300 | |
| $0.981 | -0.019 | -1.9% | $1.030 | $1.030 | $0.981 | 329,500 | |
| $1.000 | -0.040 | -3.8% | $1.050 | $1.075 | $1.000 | 769,800 | |
| $1.040 | -0.020 | -1.9% | $1.060 | $1.070 | $1.040 | 336,200 | |
| $1.060 | +0.040 | +3.9% | $1.040 | $1.080 | $1.025 | 615,700 | |
| $1.020 | -0.015 | -1.4% | $1.040 | $1.070 | $1.010 | 531,700 | |
| $1.035 | +0.025 | +2.5% | $1.000 | $1.045 | $0.981 | 623,900 | |
| $1.010 | +0.027 | +2.7% | $0.987 | $1.030 | $0.970 | 229,000 | |
| $0.983 | +0.003 | +0.3% | $0.977 | $1.000 | $0.970 | 218,000 | |
| $0.980 | -0.010 | -1.0% | $0.990 | $1.005 | $0.970 | 293,500 | |
| $0.990 | -0.020 | -2.0% | $1.010 | $1.030 | $0.986 | 472,600 | |
| $1.010 | -0.020 | -1.9% | $1.020 | $1.040 | $1.000 | 261,200 | |
| $1.030 | -0.020 | -1.9% | $1.050 | $1.050 | $1.010 | 377,500 | |
| $1.050 | 0.000 | 0.0% | $1.050 | $1.060 | $1.020 | 261,200 | |
| $1.050 | +0.040 | +4.0% | $1.010 | $1.070 | $1.005 | 377,500 | |
| $1.010 | -0.020 | -1.9% | $1.020 | $1.025 | $0.982 | 335,900 | |
| $1.030 | +0.010 | +1.0% | $1.020 | $1.050 | $1.010 | 289,000 | |
| $1.020 | -0.040 | -3.8% | $1.070 | $1.070 | $1.020 | 347,400 | |
| $1.060 | +0.010 | +1.0% | $1.070 | $1.080 | $1.040 | 270,500 | |
| $1.050 | +0.020 | +1.9% | $1.030 | $1.060 | $0.994 | 466,200 | |
| $1.030 | +0.045 | +4.6% | $0.980 | $1.035 | $0.980 | 416,428 | |
| $0.985 | -0.011 | -1.2% | $0.990 | $1.000 | $0.960 | 249,742 | |
| $0.996 | +0.039 | +4.1% | $0.975 | $1.010 | $0.970 | 308,300 | |
| $0.957 | -0.022 | -2.2% | $0.985 | $0.987 | $0.930 | 303,400 | |
| $0.979 | -0.003 | -0.3% | $0.994 | $1.020 | $0.961 | 805,600 | |
| $0.982 | -0.038 | -3.7% | $1.010 | $1.030 | $0.982 | 379,800 | |
| $1.020 | +0.010 | +1.0% | $1.010 | $1.035 | $1.010 | 434,800 | |
| $1.010 | -0.030 | -2.9% | $1.040 | $1.050 | $1.000 | 509,500 | |
| $1.040 | 0.000 | 0.0% | $1.030 | $1.058 | $1.030 | 398,300 | |
| $1.040 | +0.020 | +2.0% | $1.030 | $1.060 | $1.000 | 821,300 | |
| $1.020 | -0.030 | -2.9% | $1.060 | $1.100 | $1.000 | 713,500 | |
| $1.050 | -0.030 | -2.8% | $1.050 | $1.090 | $1.030 | 1,032,400 | |
| $1.080 | -0.050 | -4.4% | $1.100 | $1.120 | $1.065 | 901,700 | |
| $1.130 | +0.070 | +6.6% | $1.100 | $1.150 | $1.080 | 1,049,900 | |
| $1.060 | +0.074 | +7.5% | $0.990 | $1.070 | $0.953 | 668,100 | |
| $0.986 | +0.094 | +10.5% | $0.902 | $1.020 | $0.896 | 733,800 | |
| $0.892 | +0.002 | +0.2% | $0.907 | $0.920 | $0.880 | 324,400 | |
| $0.890 | -0.026 | -2.8% | $0.934 | $0.940 | $0.887 | 407,400 | |
| $0.916 | +0.015 | +1.7% | $0.895 | $0.930 | $0.890 | 259,400 |
- Ticker
- NASDAQ:CGTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
Latest earnings call · Mar 26, 2026
Cognition Therapeutics (NASDAQ:CGTX) Q4 2025 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 19 slides
Calls
Replays
Cognition Therapeutics (NASDAQ:CGTX) Q4 2025 Earnings Call
Thu, Mar 26, 2026 · 8:30 AM ET
Watch TranscriptCognition Therapeutics (NASDAQ:CGTX) Q4 2024 Earnings Call
Thu, Mar 20, 2025 · 8:00 AM ET
Watch TranscriptCognition Therapeutics (NASDAQ:CGTX) Q2 2024 Earnings Call
Thu, Aug 08, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
Oct 22, 2026
Closed $0.701 (-6.2%) on Oct 22, 2026
Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045
Oct 13, 2026
Closed $0.802 (-6.4%) on Oct 13, 2026
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
Sep 29, 2026
Closed $0.954 (+1.7%) on Sep 29, 2026
Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
Sep 8, 2026
Closed $1.01 (-1.9%) on Sep 8, 2026
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
Aug 6, 2026
Closed $1.08 (-4.4%) on Aug 7, 2026
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
Jul 13, 2026
Closed $1.02 (-6.4%) on Jul 13, 2026
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
Jun 24, 2026
Closed $1.02 (-38.2%) on Jun 24, 2026
Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045
Jun 16, 2026
Closed $1.26 (+4.1%) on Jun 16, 2026
Cognition Therapeutics Participating in Upcoming Investor Conferences
Jun 1, 2026
Closed $1.25 (+5.9%) on Jun 1, 2026
Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis
May 21, 2026
Closed $1.25 (-3.1%) on May 21, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 19 slides · August 2026
Jefferies Global Healthcare Conference 2026
Conference · 17 slides · Jun 4, 2026
Investor Presentation (March 2026)
Investor deck · 31 slides · Mar 26, 2026
Investor Presentation (March 2026)
Investor deck · 31 slides · March 2026
Cognition Therapeutics, Inc. on 6ix
- News releases
- 25 in the last 12 months · 144 in all · newest Oct 22, 2026 · oldest 2021
- Calls
- 7 calls with a replay · 7 with a transcript · latest Mar 26, 2026
- Decks
- 31 decks · latest August 2026
Where Cognition Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CGTX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CGTX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Cognition Therapeutics, Inc.